case_id,num_combos,combos,patient_info,expected_md5,document_name
Case16126,3,"['top3_10retrieve_gpt_5_mini_gpt_5_mini', 'top3_10retrieve_gpt_5_gpt_5_mini', 'top3_30retrieve_gpt_5_gpt_5_mini']","The patient is a 6-week-old infant being evaluated for multiple congenital anomalies and BRCA1 and BRCA2 testing has been ordered by a gynecologist. FISH testing was previously performed and was nondiagnostic, the parents are reported to be consanguineous, pre-test counseling has been completed with plans for post-test follow-up with a genetic counselor, and testing will be billed through BCBS_FEP.",c5c2b854957d06467835e88a963d0c82,BCBS_FEP_20402 Germline Genetic Testing for.pdf
Case2666,2,"['top3_10retrieve_gpt_5_gpt_5_mini', 'top3_30retrieve_gpt_5_gpt_5_mini']","A 21-year-old woman with a major congenital cardiac anomaly is undergoing BRCA1/2 testing at the request of her obstetrician, and prior fluorescence in situ hybridization (FISH) testing was nondiagnostic; she reports a father with metastatic prostate cancer prompting consideration of hereditary cancer evaluation, pre-test counseling was completed with a genetic specialist and plans for post-test follow-up are in place, and she has coverage through the Blue Cross Blue Shield Federal Employee Program (FEP).",c5c2b854957d06467835e88a963d0c82,BCBS_FEP_20402 Germline Genetic Testing for.pdf
Case13983,1,['top3_10retrieve_gpt_5_gpt_5_mini'],"The patient is a 7-week-old infant being evaluated for a high-risk brief resolved unexplained event (BRUE) with a significantly abnormal electrocardiogram (ECG) that raises concern for an underlying channelopathy, arrhythmia, cardiomyopathy, myocarditis, or structural heart disease, and whole genome sequencing (WGS) is being pursued at the request of the ordering gynecologist given the concerning cardiac findings and family history. Prior fluorescent in situ hybridization testing was nondiagnostic. The maternal uncle has a history of unexplained developmental regression reported as unrelated to autism or epilepsy and this family history prompted consideration of an inherited etiology. Pre-test counseling was completed with a genetic counselor and plans are in place for post-test follow-up, and testing will be billed through BCBS_FEP.",d5e9701c13de1dca302ad0ce45524039,BCBS_FEP_204102 Whole Exome and.pdf
Case14195,1,['top3_10retrieve_gpt_5_mini_gpt_5_mini'],"An 18-year-old with a history of a major congenital cardiac anomaly is being evaluated by an oncologist and referred for BRCA1/2 testing because of a family history that includes a maternal uncle with dystonia and ataxia, prior karyotype testing was nondiagnostic, no pretest genetic counseling has been conducted, and the patient has coverage through BCBS_FEP.",c5c2b854957d06467835e88a963d0c82,BCBS_FEP_20402 Germline Genetic Testing for.pdf
Case15202,1,['top3_10retrieve_gpt_5_gpt_5_mini'],"The patient is a 65-year-old woman with a history of malignant phyllodes tumors of the breast who was referred by her gynecologist for BRCA1 and BRCA2 testing to evaluate possible hereditary breast and ovarian cancer risk, and she reports a sister with a persistent and severe immunologic or hematologic disorder in the family; Fragile X testing was previously performed and was nondiagnostic, pre-test counseling was completed with a genetic specialist with plans for post-test follow-up, and she has coverage through BCBS_FEP.",c5c2b854957d06467835e88a963d0c82,BCBS_FEP_20402 Germline Genetic Testing for.pdf
Case15458,1,['top3_10retrieve_gpt_5_gpt_5_mini'],"The patient is a 19-year-old woman with a personal history of breast cancer who is being evaluated for BRCA1 and BRCA2 testing because of a family history that includes ovarian cancer in a maternal aunt and a close relative with metastatic or intraductal/cribriform prostate cancer, prior fluorescence in situ hybridization (FISH) testing was nondiagnostic, the testing was ordered by a nurse practitioner, and the patient completed pre-test genetic counseling with plans for post-test follow-up, with coverage through BCBS_FEP.",c5c2b854957d06467835e88a963d0c82,BCBS_FEP_20402 Germline Genetic Testing for.pdf
Case15570,1,['top3_10retrieve_gpt_5_gpt_5_mini'],"The patient is a 15-year-old being followed by a general pediatrician for Hirschsprung disease and the clinician has requested BRCA1 and BRCA2 testing despite the pediatric gastrointestinal indication. Prior karyotype testing was nondiagnostic and the family history is notable for a mother with bipolar disorder, with no other cancer history documented. There is no documentation of pre-test genetic counseling and the test was ordered with coverage through the Blue Cross Blue Shield Federal Employee Program (FEP).",c5c2b854957d06467835e88a963d0c82,BCBS_FEP_20402 Germline Genetic Testing for.pdf
Case22,1,['top3_10retrieve_gpt_5_gpt_5_mini'],"An 18-year-old man is undergoing BRCA1/2 testing to evaluate for a possible hereditary predisposition in the setting of high-risk prostate cancer with intraductal/cribriform histology and metastatic disease, with testing ordered by his neurologist; his father also had metastatic high-risk prostate cancer with intraductal/cribriform features. A prior chromosomal microarray (CMA) was nondiagnostic. He completed pre-test counseling and will return for post-test follow-up with a genetic counselor, and the testing is being pursued with coverage through the Blue Cross Blue Shield Federal Employee Program (BCBS_FEP).",c5c2b854957d06467835e88a963d0c82,BCBS_FEP_20402 Germline Genetic Testing for.pdf
Case3223,1,['top3_30retrieve_gpt_5_gpt_5_mini'],"The 75-year-old woman was referred by her general practitioner for BRCA1 and BRCA2 testing because her sister had epithelial ovarian cancer, and she has a history of a major congenital cardiac anomaly for which a chromosomal microarray (CMA) was previously performed and reported as nondiagnostic. There is no documentation of pre-test genetic counseling, and she has coverage through BCBS_FEP.",c5c2b854957d06467835e88a963d0c82,BCBS_FEP_20402 Germline Genetic Testing for.pdf
Case5834,1,['top3_30retrieve_gpt_5_gpt_5_mini'],The patient is 67 years old and is under the care of neurology for a lifelong history of severe intellectual disability diagnosed by age 18 and is being referred for chromosomal microarray (CMA) testing to evaluate a genomic etiology for the developmental disorder. No prior genetic testing has been performed. Pre-test counseling has been completed with a genetic counselor on multiple occasions and plans for post-test follow-up were discussed. The family history is notable for the patient's mother having had ovarian cancer and testing is being requested with coverage through the Blue Cross Blue Shield Federal Employee Program (BCBS_FEP).,8340e5b0ce4959eccfb2cb295edb47f3,BCBS_FEP_20459 Genetic Testing for Developmental.pdf
Case6747,1,['top3_30retrieve_gpt_5_mini_gpt_5'],"A 12-year-old child with multiple congenital anomalies is undergoing whole genome sequencing (WGS) ordered by the medical geneticist to evaluate a suspected genetic etiology. Chromosomal microarray (CMA) testing was previously performed and was nondiagnostic. The family reports a sibling with developmental delay, pre-test counseling has been completed and post-test counseling is planned, and the patient has coverage through BCBS_FEP.",d5e9701c13de1dca302ad0ce45524039,BCBS_FEP_204102 Whole Exome and.pdf
Case7447,1,['top1_10retrieve_gpt_5_mini_gpt_5_mini'],"At 33 weeks' gestation, fetal imaging raises concern for an isolated severe congenital heart defect and the cardiologist has ordered whole genome sequencing (WGS) to evaluate for a possible genetic etiology and to guide postnatal management; prior fragile X testing was nondiagnostic, family history is notable for a maternal aunt with triple-negative breast cancer, there is no documentation of pre-test genetic counseling, and coverage is through BCBS_FEP.",d5e9701c13de1dca302ad0ce45524039,BCBS_FEP_204102 Whole Exome and.pdf
